Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 532296 | NSE Symbol : GLENMARK | ISIN : INE935A01035 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	7,891.12	8,220.66	8,141.58	7,567.93	6,712.63
Sale of Products	7,627.81	7,998.18	7,991.98	7,424.98	6,413.14
Sale of Services	21.95	21.49	25.40	25.93	78.06
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	241.36	201.00	124.20	117.02	221.43
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	7,891.12	8,220.66	8,141.58	7,567.93	6,712.63
Other Income	1,168.02	985.94	614.63	396.24	606.79
Total Revenue	9,059.14	9,206.60	8,756.21	7,964.17	7,319.42
Changes in Inventories	-103.07	-31.37	-16.13	5.24	48.77
Cost of Material Consumed	2,990.41	3,035.88	2,993.04	2,628.58	2,251.98
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	322.78	391.19	481.62	315.96	365.24
Employee Benefits	1,434.78	1,346.51	1,193.20	1,107.40	1,072.33
Total Other Expenses	2,004.56	2,005.68	1,801.64	1,620.43	1,670.08
Manufacturing / Operating Expenses	372.71	303.56	298.10	270.83	238.33
Administrative and Selling Expenses	1,306.69	1,342.28	1,153.58	991.30	1,060.23
Other Expenses	325.15	359.85	349.97	358.30	371.53
Finance Costs	277.11	206.82	236.04	265.90	256.39
Depreciation and Amortization	202.16	184.15	159.70	150.82	138.54
Total Expenses	7,128.73	7,138.86	6,849.10	6,094.31	5,803.33
Profit Before Exceptional Items and Tax	1,930.42	2,067.74	1,907.11	1,869.87	1,516.09
Exceptional Items Before Tax	5,070.33	-495.87	430.33	73.89	18.55
Profit Before Extraordinary Items and Tax	7,000.75	1,571.87	2,337.45	1,943.76	1,534.64
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	7,000.75	1,571.87	2,337.45	1,943.76	1,534.64
Taxation	1,833.46	363.11	339.66	294.31	180.10
Current Tax	1,049.99	386.93	411.08	343.62	269.24
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	783.46	-23.83	-71.42	-49.31	-89.14
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	5,167.29	1,208.77	1,997.79	1,649.45	1,354.55
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	5,167.29	1,208.77	1,997.79	1,649.45	1,354.55
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	5,167.29	1,208.77	1,997.79	1,649.45	1,354.55
Earning Per Share - Basic	183.13	42.84	70.80	58.46	48.00
Earning Per Share - Diluted	183.12	42.84	70.80	58.46	48.00

LOGIN HERE

LOGIN HERE

Glenmark Pharmaceuticals Ltd

Profit and Loss